While North America holds the lion’s share of the anthrax vaccine market, Asia Pacific is poised to be the fastest-growing regional market, expanding at a CAGR of 8.8% to reach US$ 211.26 million by ...

The use of anthrax as a bioweapon is rare, but devastating. This new treatment might one day save people that are beyond the ...

在一项新的《Nature Microbiology》研究中，匹兹堡大学研究人员表明，一种生长因子混合物逆转了患有炭疽病的小鼠中本应致命的细胞损伤，表明这种方法可以被改编用于超出临界点的患者。

University of Pittsburgh researchers discovered that a mix of growth factors can rescue cells from late-stage anthrax damage ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once the disease has progressed beyond the "point of no return" after just a few ...

Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once ...

Results provide proof-of-concept that ERK pathway reactivation might be an effective, biologically based therapy to prevent anthrax-induced lethality.

We need new approaches to treat this later stage of the disease.” When B. anthracis enters the body through inhalation, ingestion, injection or contact with skin, it produces two proteins that ...

These substances trigger a self-destruction ... Anthrax, an infectious disease caused by the bacterium Bacillus anthracis, is often treatable in its early stages. But once the disease has ...

CDC scientists were studying the bacteria in a high-level biosecurity lab and then transferred the samples to three lower-security labs without first properly inactivating the live microbes. Workers ...

The 24 pathogen families listed in the reference tool include microorganisms that cause Covid-19 and Nipah virus, among ...